[SLN] YoY Quarter Result on 30-Sep-2016 [#Q3]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
29-Sep-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 21.67%
YoY- -48.08%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 122 0 0 385 0 4 38 21.44%
PBT -6,636 -5,370 1,441 -2,410 -2,644 -3,178 -2,798 15.47%
Tax 950 507 508 557 1,392 446 0 -
NP -5,686 -4,862 1,949 -1,854 -1,252 -2,732 -2,798 12.53%
Tax Rate - - -35.30% - - - - -
Total Cost 5,808 4,862 -1,949 2,239 1,252 2,736 2,836 12.68%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin -4,660.66 0.00 0.00 -481.43 0.00 -68,300.00 -7,363.16 -7.33%
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS -0.22 -0.21 0.08 -0.08 -0.05 -0.16 -0.18 3.39%
EPS Diluted -0.22 -0.21 0.08 -0.08 -0.05 -0.16 -0.18 3.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.